Fisher Asset Management LLC Makes New $271.85 Million Investment in iShares U.S. Pharmaceuticals ETF $IHE

Fisher Asset Management LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,704,418 shares of the company’s stock, valued at approximately $271,848,000. Fisher Asset Management LLC owned 0.18% of iShares U.S. Pharmaceuticals ETF as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Russell Investments Group Ltd. increased its stake in iShares U.S. Pharmaceuticals ETF by 148.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 467 shares of the company’s stock worth $47,000 after purchasing an additional 279 shares in the last quarter. Fifth Third Bancorp lifted its stake in iShares U.S. Pharmaceuticals ETF by 16.6% during the third quarter. Fifth Third Bancorp now owns 7,898 shares of the company’s stock valued at $794,000 after buying an additional 1,125 shares in the last quarter. Moneco Advisors LLC lifted its stake in iShares U.S. Pharmaceuticals ETF by 45.0% during the third quarter. Moneco Advisors LLC now owns 10,026 shares of the company’s stock valued at $1,008,000 after buying an additional 3,110 shares in the last quarter. Simplex Trading LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF in the third quarter worth about $81,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 7,058.1% in the third quarter. Allspring Global Investments Holdings LLC now owns 7,516 shares of the company’s stock worth $744,000 after buying an additional 7,411 shares during the period.

iShares U.S. Pharmaceuticals ETF Price Performance

iShares U.S. Pharmaceuticals ETF stock opened at $110.25 on Friday. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $79.82 and a fifty-two week high of $111.98. The firm’s 50 day simple moving average is $102.97 and its 200-day simple moving average is $95.73. The company has a market cap of $1.71 billion, a P/E ratio of 17.75 and a beta of 0.47.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.